Trial
NCT05091866
Natural Progesterone for the Treatment of Recurrent Glioblastoma
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Emory University
Collaborators
National Cancer Institute (NCI)
Condition
Gliosarcoma
Intervention
Quality-of-Life Assessment
Why stopped
Review of Drug Supply
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-05-05